This inventor holds 2 USPTO granted patents. Top assignees: Haemopep Pharma Gmbh, Pharma Bissendorf Peptide Gmbh, Other. Active years: 1995-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1997
Title: Jeanette M Alt: Innovator in Peptide Research
Introduction
Jeanette M Alt is a notable inventor based in Burgwedel, Germany. She has made significant contributions to the field of peptide research, particularly in the development of novel peptide fragments with medical applications. With a total of 2 patents, her work has implications for the treatment of various medical conditions.
Latest Patents
Jeanette's latest patents include the "Cardiodilatin fragment, process for preparing same and use thereof." This patent describes a peptide fragment that comprises the amino acid sequence 95-126 of ANF/CDD 1-126 (gamma-hANaP), which is formed in the kidney. The fragment urodilatin (ANF/CDD 95-126) has a specific amino acid sequence, wherein R.sup.1 and R.sup.2 represent further peptide fragments of ANF/CDD 1-126 (gamma-hANaP). The amino acid sequence R.sup.1 is Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser, while R.sup.2 is Asn-Ser-Phe-Arg-Tyr. The patent further details processes for the preparation and recovery of this new peptide fragment, as well as a medicament containing urodilatin (ANF/CDD 95-126) and its medical indications.
Career Highlights
Throughout her career, Jeanette has worked with various companies, including Pharma Bissendorf Peptide GmbH. Her expertise in peptide research has positioned her as a key figure in the development of innovative medical treatments.
Collaborations
Jeanette has collaborated with notable individuals in her field, including Wolf-Georg Forssmann and Gerhard Becker. These collaborations have contributed to her success and the advancement of peptide research.
Conclusion
Jeanette M Alt is a pioneering inventor whose work in peptide research has led to significant advancements in medical treatments. Her contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile